News & Press Releases

Access the latest news about Lipidor, our current projects, publications and collaborations. Thank you for your interest in Lipidor!

Subscribe

January 24, 2024

Lipidor completes SEK 1.7 million sale of animal segment patent

STOCKHOLM, Sweden, 24th January 2024 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that one of the company's patents, previously out-licensed to Emollivet AB, has now been sold to the same party. The sale is aimed at strengthening Lipidor's short term cash position. Since its inception…

June 29, 2023

Lipidor – Announcement of short-term funding

STOCKHOLM, Sweden, 29th June 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announces that financing of SEK 2 million…

June 22, 2023

Lipidor – Swedish Medical Products Agency confirms clinical plan for new version of AKP02

STOCKHOLM, Sweden, 22nd June 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) announced today that the Swedish Medical Products…

June 8, 2023

Bulletin from the Annual General Meeting of Lipidor AB (publ)

The following resolutions were passed at the Annual General Meeting (the “AGM”) of Lipidor AB (publ) (the “Company”) on 8 June 2023…

May 26, 2023

Lipidor updates on development of AKP02

STOCKHOLM, Sweden, 26th May 2023 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) is targeting a new Phase III study…

May 11, 2023

Lipidor AB (publ) publishes interim report for Q1 2023

STOCKHOLM, Sweden, 11 May 2023 – Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its interim report for the…

May 9, 2023

NOTICE OF ANNUAL GENERAL MEETING IN LIPIDOR AB (PUBL)

NOTE: This is an unofficial translation of the original Swedish notice. In case of discrepancies, the Swedish version shall prevail. The shareholders…

April 26, 2023

Lipidor AB (publ) publishes annual report for 2022

STOCKHOLM, Sweden, 26th April 2023 – Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its annual report for the…

February 22, 2023

Lipidor AB (publ) publishes year-end report for 2022

STOCKHOLM, Sweden, 22 February 2023 – Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its year-end report for the…

January 17, 2023

Bulletin from the extraordinary general meeting of Lipidor AB (publ)

Lipidor AB (publ) (“Lipidor” or the “Company”) held an extraordinary general meeting (the “EGM”) on 17 January 2023 in Stockholm. The EGM…

December 23, 2022

NOTICE OF EXTRAORDINARY GENERAL MEETING IN LIPIDOR AB (PUBL)

The shareholders of Lipidor AB (publ) reg. no. 556779-7500 (“Lipidor” or the “Company”) are hereby given notice to attend the Extraordinary General…